drugset / Trial / NCT07121244
A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer
Non-randomizedSequentialOpen-labelTreatment
Summary
A phase 1 study of 68Ga-R11228 and 177Lu-R11228 in breast cancer.
Timeline
- Start
- 2025-10-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-30
Outcome
Outcome not reported
Stopped (Business): “Sponsor decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 177Lu-R11228 | Small molecule | — | — |
| Subject | 68Ga-R11228 | Small molecule | — | — |